Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease

Movement Disorders

Volumn 26, Issue 3, 2011, Pages 527-533

  Morelli, Maurizio ^a   Arabia, Gennarina ^a   Salsone, Maria ^a   Novellino, Fabiana ^a   Giofrè, Laura ^a   Paletta, Rosina ^a   Messina, Demetrio ^b   Nicoletti, Giuseppe ^b   Condino, Francesca ^b   Gallo, Olivier ^b   Lanza, Pierluigi ^b   Quattrone, Aldo ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

Magnetic resonance parkinsonism index; Midbrain area pons area ratio; Parkinson's disease; Progressive supranuclear palsy

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRADYKINESIA; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; FEMALE; GAZE PARALYSIS; HOEHN YAHR SCORE; HUMAN; MAGNETIC RESONANCE PARKINSONISM INDEX; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; MIDBRAIN PONS RATIO; MIDDLE CEREBELLAR PEDUNCLE; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PONS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RIGIDITY; SACCADIC EYE MOVEMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SUPERIOR CEREBELLAR PEDUNCLE; TREATMENT RESPONSE; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; AGED, 80 AND OVER; BRAIN MAPPING; BRAIN STEM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 79953286290     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23529     Document Type: Article

References (29)

1. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125: 861-870.
2. Osaki Y, Ben-Shlomo Y, Lees AJ, et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004; 19: 181-189.
3. Quattrone A, Nicoletti G, Messina D, et al. MR Imaging Index for differentiation of progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246: 214-221.
4. Brooks DJ, Seppi K. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 2009; 7: 949-964.
5. Hotter A, Esterhammer R, Schocke MFH, Seppi K. Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism. Mov Disord 2009; 24: S711-S720.
6. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001; 58: 1076-1079.
7. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005; 64: 2050-2055.
8. Paviour DC, Price SL, Stevens JM, Lees AJ, Fox NC. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005; 64: 675-679.
9. Nicoletti G, Tonon C, Lodi R, et al. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord 2008; 23: 2370-2376.
10. Nicoletti G, Fera F, Condino F, et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology 2006; 239: 825-830.
11. Nicoletti G, Lodi R, Condino F, et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006; 129: 2679-2687.
12. Gröschel K, Kastrup A, Litvan I, Schulz JB. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology 2006; 66: 949-950.
13. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1-9.
14. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
15. Lachenbruch PA, Lynch CJ. Assessing screening tests: extensions of McNemar's test. Stat Med 1998; 17: 2207-2217.
16. Marshall V, Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord 2003; 12; 1415-1423.
17. Rascol O, Schelosky L. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorder. Mov Disord 2009; 24: S732-S741.
18. Burn DJ, Lees AJ. Progressive supranuclear palsy: where are we now? Lancet Neurol 2002; 1: 359-369.
19. Richardson JC, Steele J, Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of "heterogenous system degeneration". Trans Am Neurol Assoc 1963; 88: 25-29.
20. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009; 8: 270-279.
21. Williams DR, De Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128: 1247-1258.
22. Schulz JB, Skalej M, Wedekind D, et al. Magnetic Resonance Imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999; 45: 65-74.
23. Seppi K, Schocke MFH, Esterhammer R, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology 2003; 60: 922-927.
24. Federico F, Simone IL, Lucivero V, et al. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders. Mov Disord 1997; 12: 903-909.
25. Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, Quinn NP. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000; 54: 697-702.
26. Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003; 210: 57-60.
27. Lehéricy S, Hartmann A, Lannuzel A, et al. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy. Brain 2010; 133: 2410-2425.
28. Hussl A, Mahlknecht P, Scherfler C, Esterhammer R, Schocke M, Poewe W, Seppi K. Diagnostic accuracy of the MR parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy. Mov Disord 2010; 25: 2444-2449.
29. Litvan I, Bathia KP, Burn DJ, et al. Movement Disorder Society Scientific Issue Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003; 18: 467-486.